Latest Germany Startup Funding Rounds
Startup funding in Germany: recent rounds, the companies behind them and their participating investors.
- Rounds
- 187 Jan 1 – Oct 12, 2026
- Disclosed funding
- $9.1B 150 disclosed amounts
- Median round
- $7.1M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
EthrisCompany profile Ethris develops inhaled mRNA therapeutics and vaccines for respiratory diseases, using proprietary RNA stabilization and nanoparticle delivery platforms. Ethris develops inhaled mRNA therapeutics and vaccines for respiratory diseases, using proprietary RNA stabilization and nanoparticle delivery platforms. | €30M | HERA Invest financingUndisclosed | Biotech | Germany | Investors | |
FuroCompany profile Furo provides AI software that plans, controls and optimizes commercial and industrial battery-storage systems, including their participation in energy markets. Furo provides AI software that plans, controls and optimizes commercial and industrial battery-storage systems, including their participation in energy markets. | $4M | Funding roundUndisclosed | Climate tech | Germany | Investors | |
KittsCompany profile Kitts is a marketplace where football-shirt fans can buy and sell jerseys and build a public collection of the kits they value. Kitts is a marketplace where football-shirt fans can buy and sell jerseys and build a public collection of the kits they value. | Undisclosed | Strategic investmentUndisclosed | Ecommerce | Germany | Investors | |
| G GrubelCompany profile Grubel is an AI research lab developing matter-specific AI for law firms and legal teams. For each case, its system curates task-relevant data, adapts models and agents to that matter at inference time, and evaluates their work against legal-task requirements, aiming to handle complex legal work with stronger case context and confidentiality than a general-purpose assistant. Grubel is an AI research lab developing matter-specific AI for law firms and legal teams. For each case, its system curates task-relevant data, adapts models and agents to that matter at inference time, and evaluates their work against legal-task requirements, aiming to handle complex legal work with stronger case context and confidentiality than a general-purpose assistant. | €3M | Pre-seed | Enterprise software | Germany | Investors | |
| P PhagestackCompany profile A phage-discovery and development company that uses bacteriophage libraries, bioinformatics and machine learning to identify targeted solutions against bacterial strains. A phage-discovery and development company that uses bacteriophage libraries, bioinformatics and machine learning to identify targeted solutions against bacterial strains. | Undisclosed | NRW.BANK investmentUndisclosed | Biotech | Germany | Investors | |
LimetaxCompany profile Limetax combines a network of tax advisory firms with its own DATEV-based AI platform and central services that help German tax firms automate routine work and scale client advice. Limetax combines a network of tax advisory firms with its own DATEV-based AI platform and central services that help German tax firms automate routine work and scale client advice. | €36M | Pre-seed equity and acquisition facilityPre-seed | Enterprise software | Germany | Investors | |
| A AERLINCompany profile A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools. A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools. | Undisclosed | Seed | Mobility | Germany | Investors | |
| A AllogeneticsCompany profile Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. | €3.8M | Pre-Series ASeries A | Biotech | Germany | Investors | |
| FM FRYTE MobilityCompany profile An open software platform that links electric-truck route planning and logistics systems with charging networks so fleets can reserve compatible charging slots across providers. An open software platform that links electric-truck route planning and logistics systems with charging networks so fleets can reserve compatible charging slots across providers. | €3.5M | Seed | Mobility | Germany | Investors | |
| VT VC TradeCompany profile VC Trade operates a digital marketplace and transaction platform for institutional debt financing. Banks, issuers, arrangers and investors use it to originate, syndicate and administer instruments such as Schuldschein loans and other private-debt products through connected digital workflows. VC Trade operates a digital marketplace and transaction platform for institutional debt financing. Banks, issuers, arrangers and investors use it to originate, syndicate and administer instruments such as Schuldschein loans and other private-debt products through connected digital workflows. | Undisclosed | Minority equity investmentUndisclosed | Fintech | Germany | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1High-Tech Gründerfonds
Finches, Kontext, Arcos
29rounds2led - 2Bayern Kapital
Finches, Arcos, HyImpulse
10rounds0led - 3IBB Ventures
Amara, AERLIN, sci2sci
9rounds2led - 4NRW.BANK
NUNOS, syte, Phagestack
9rounds0led - 5Cherry Ventures
RobCo, Integral, Moss
8rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.